Keyphrases
Malaria
82%
Cerebral Malaria
69%
Falciparum Malaria
61%
Plasmodium Falciparum
58%
Ghana
53%
Uncomplicated Malaria
36%
Ghanaian children
35%
T Cells
29%
Interleukin-4 (IL-4)
29%
Visceral Leishmaniasis
29%
Interferon-γ
28%
Leishmania Donovani
21%
Severe Malarial Anaemia
21%
Severe Malaria
19%
Experimental Cerebral Malaria
19%
Erythropoietin
19%
Leishmania
18%
Infected Erythrocytes
16%
Severe Anemia
16%
T Cell Response
15%
Teaching Hospital
15%
Plasmodium Infection
15%
Pneumocystis Jirovecii
14%
African children
14%
Peripheral Blood Mononuclear Cells
14%
Amodiaquine
13%
Artesunate-mefloquine
13%
Soluble Leishmania Antigen
13%
Interleukin-10
13%
Artemether-lumefantrine
13%
Variant Surface Antigens
13%
Kenya
13%
Anemia
12%
Parasitemia
12%
Surgical Site Infection
12%
Endothelial Glycocalyx
12%
Baringo
12%
Lipophosphoglycan
11%
Glycocalyx
11%
Confidence Interval
11%
Artemisinin-based Combination Therapy
11%
Murine Model
10%
Antibiotics
10%
Denmark
10%
Travellers
10%
Non-associated
10%
Sickle Cell Disease
10%
Polymorphism
10%
Clinical Malaria
9%
Artesunate
9%
Immunology and Microbiology
Plasmodium falciparum
100%
T Cell
47%
Leishmania
32%
Visceral Leishmaniasis
29%
Interferon Gamma
25%
Erythrocyte
24%
Blood Level
21%
Monospecific Antibody
21%
Mouse
19%
Interleukin 4
18%
Prevalence
17%
Surface Property
15%
Blood Plasma
14%
Glycocalyx
14%
Parasitemia
14%
Peripheral Blood Mononuclear Cell
13%
Plasmodium berghei
12%
Lipophosphoglycan
11%
Erythropoietin
11%
Cytokine
11%
Leishmaniasis
10%
Human Immunodeficiency Virus
10%
Membrane Antigen
10%
Leishmania donovani
10%
Antibody Response
9%
Gamma Delta T Cell
8%
Mannan-Binding Lectin
8%
Sickle Cell
8%
Vaccination Policy
8%
Tumor Necrosis Factor Alpha
8%
Promastigote
7%
Interleukin 10
7%
Enzyme-Linked Immunosorbent Assay
7%
CD4
6%
Adoptive Immunity
6%
Infectious Disease
6%
Neopterin
6%
Immunoglobulin G
6%
Vaccine Efficacy
6%
Matrix-Assisted Laser Desorption-Ionization
5%
Time-of-Flight Mass Spectrometry
5%
Antimicrobial Resistance
5%
Chloroquine
5%
Merozoite Surface Protein 1
5%
Schistosoma Mansoni
5%
Pneumocystis Jiroveci
5%
Babesia microti
5%
Artemether
5%
Humoral Immunity
5%
Gram-Negative Bacteria
5%
